Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats
We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and...
Saved in:
Published in | Journal of molecular and cellular cardiology Vol. 51; no. 2; pp. 144 - 155 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.08.2011
|
Subjects | |
Online Access | Get full text |
ISSN | 0022-2828 1095-8584 1095-8584 |
DOI | 10.1016/j.yjmcc.2011.04.006 |
Cover
Abstract | We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy.
This article is part of Special Issue Item Group entitled "Possible Editorial".
► The long-term in vivo cardiovascular effects of resistin are investigated using AAV9. ► Resistin overexpression in the myocardium induced systolic dysfunction. ► Molecular markers of stress and hypertrophy are increased by resistin in vivo. ► Resistin overexpression induced oxidative stress, myocardial fibrosis and apoptosis. ► Resistin-induced oxidative stress may underlie mechanism governing cardiac remodeling. |
---|---|
AbstractList | Abstract We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo , along with an apoptotic molecular phenotype in vivo and in vitro . Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial". We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial". ► The long-term in vivo cardiovascular effects of resistin are investigated using AAV9. ► Resistin overexpression in the myocardium induced systolic dysfunction. ► Molecular markers of stress and hypertrophy are increased by resistin in vivo. ► Resistin overexpression induced oxidative stress, myocardial fibrosis and apoptosis. ► Resistin-induced oxidative stress may underlie mechanism governing cardiac remodeling. We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial". We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial".We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular effects of resistin, we induced in vivo overexpression of resistin using adeno-associated virus serotype 9 injected by tail vein in rats and compared to control animals. Ten weeks after viral injection, overexpression of resistin was associated with increased ratio of left ventricular (LV) weight/body weight, increased end-systolic LV volume and significant decrease in LV contractility, measured by the end-systolic pressure volume relationship slope in LV pressure volume loops, compared to controls. At the molecular level, mRNA expression of ANF and β-MHC, and protein levels of phospholamban were increased in the resistin group without a change in the level of SERCA2a protein expression. Increased fibrosis by histology, associated with increased mRNA levels of collagen, fibronectin and connective tissue growth factor were observed in the resistin-overexpressing hearts. Resistin overexpression was also associated with increased apoptosis in vivo, along with an apoptotic molecular phenotype in vivo and in vitro. Resistin-overexpressing LV tissue had higher levels of TNF-α receptor 1 and iNOS, and reduced levels of eNOS. Cardiomyocytes overexpressing resistin in vitro produced larger amounts of TNFα in the medium, had increased phosphorylation of IκBα and displayed increased intracellular reactive oxygen species (ROS) content with increased expression and activity of ROS-producing NADPH oxidases compared to controls. Long-term resistin overexpression is associated with a complex phenotype of oxidative stress, inflammation, fibrosis, apoptosis and myocardial remodeling and dysfunction in rats. This phenotype recapitulates key features of diabetic cardiomyopathy. This article is part of Special Issue Item Group entitled "Possible Editorial". |
Author | Chemaly, Elie R. Lebeche, Djamel Sheng, Jipo Kim, Maengjo Hajjar, Roger J. Zhang, Shihong Liang, Lifan Hadri, Lahouaria Kohlbrenner, Erik Chen, Jiqiu K-Raman, Purushothaman |
Author_xml | – sequence: 1 givenname: Elie R. surname: Chemaly fullname: Chemaly, Elie R. – sequence: 2 givenname: Lahouaria surname: Hadri fullname: Hadri, Lahouaria – sequence: 3 givenname: Shihong surname: Zhang fullname: Zhang, Shihong – sequence: 4 givenname: Maengjo surname: Kim fullname: Kim, Maengjo – sequence: 5 givenname: Erik surname: Kohlbrenner fullname: Kohlbrenner, Erik – sequence: 6 givenname: Jipo surname: Sheng fullname: Sheng, Jipo – sequence: 7 givenname: Lifan surname: Liang fullname: Liang, Lifan – sequence: 8 givenname: Jiqiu surname: Chen fullname: Chen, Jiqiu – sequence: 9 givenname: Purushothaman surname: K-Raman fullname: K-Raman, Purushothaman – sequence: 10 givenname: Roger J. surname: Hajjar fullname: Hajjar, Roger J. – sequence: 11 givenname: Djamel surname: Lebeche fullname: Lebeche, Djamel email: Djamel.lebeche@mssm.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21549710$$D View this record in MEDLINE/PubMed |
BookMark | eNqFktFrFDEQxoNU7LX6Fwhybz7tOskme1nEQinaCgc-qM8hl8ydOXeTM9ld3P_erFeLFuSewjDf75sw31yQMx88EvKSQkmB1m_25bTvjCkZUFoCLwHqJ2RBoRGFFJKfkQUAYwWTTJ6Ti5T2ANDwqnpGzhkVvFlRWBC1Dn5X9Bi7pfPL0Y1hGTG51OcqjBjx5yHXyQWf-3YwmJbdFIyO1ul2aae0Hbzp57b2NqNdsNg6v5vdou7Tc_J0q9uEL-7fS_L1w_svN3fF-tPtx5vrdWEEg76o6k3N0HK7RQGaS2u4oBtbiYaZBuqV3ViUdVPpSspGrHgtLV1JqXkNAg2tq0tydfQ9DJsOrUHfR92qQ3SdjpMK2ql_O959U7swqooyLhrIBq_vDWL4MWDqVeeSwbbVHsOQlFxxYACcZeWrv0c9zPiz1CyojgITQ0oRtw8SCmqOTu3V7-jUHJ0CrnJ0mWoeUcb1el5t_q9rT7DvjizmFY8Oo0rGoTdoXUTTKxvcCf7qEW9yiM7o9jtOmPZhiD6np6hKTIH6PB_WfFeUQrasRDZ4-3-Dk-N_ASqi4LY |
CitedBy_id | crossref_primary_10_1161_JAHA_122_027621 crossref_primary_10_1093_cvr_cvac093 crossref_primary_10_4103_jpcs_jpcs_19_23 crossref_primary_10_1007_s11926_013_0336_0 crossref_primary_10_1152_ajpheart_00603_2021 crossref_primary_10_3904_kjim_2016_229 crossref_primary_10_1113_JP282728 crossref_primary_10_3390_ijms21041509 crossref_primary_10_1111_eci_12942 crossref_primary_10_3389_fphys_2022_1036945 crossref_primary_10_1136_heartjnl_2012_302970 crossref_primary_10_3923_ijp_2017_212_217 crossref_primary_10_1016_j_cca_2020_11_010 crossref_primary_10_1186_s13098_017_0219_z crossref_primary_10_1016_j_lfs_2012_10_011 crossref_primary_10_1152_ajplung_00279_2013 crossref_primary_10_1155_2022_3040521 crossref_primary_10_1093_cvr_cvac046 crossref_primary_10_1152_japplphysiol_00785_2012 crossref_primary_10_1093_eurjhf_hfs111 crossref_primary_10_1186_s12872_019_01319_w crossref_primary_10_1007_s10753_022_01669_2 crossref_primary_10_1111_j_1749_6632_2012_06520_x crossref_primary_10_1002_adbi_202300211 crossref_primary_10_1093_cvr_cvab234 crossref_primary_10_1042_CS20190578 crossref_primary_10_1210_en_2013_1399 crossref_primary_10_1042_BSR20150139 crossref_primary_10_1139_y2012_053 crossref_primary_10_1002_ehf2_14064 crossref_primary_10_1016_j_tcm_2012_01_004 crossref_primary_10_1111_j_1476_5381_2011_01606_x crossref_primary_10_4070_kcj_2017_0041 crossref_primary_10_3923_ijp_2019_311_317 crossref_primary_10_1111_sji_12464 crossref_primary_10_1016_j_echo_2013_04_016 crossref_primary_10_1155_2020_8873152 crossref_primary_10_3389_fcell_2021_777258 crossref_primary_10_3390_ijms252111695 crossref_primary_10_3892_br_2016_593 crossref_primary_10_1038_s41598_020_73864_w crossref_primary_10_1111_tri_12728 crossref_primary_10_1111_1440_1681_12604 crossref_primary_10_1186_s12964_024_01842_0 crossref_primary_10_3892_br_2016_749 crossref_primary_10_3390_cells12070999 crossref_primary_10_1016_j_phrs_2022_106257 crossref_primary_10_1152_ajpendo_00202_2020 crossref_primary_10_1016_j_mce_2013_06_028 crossref_primary_10_1016_j_freeradbiomed_2012_10_555 crossref_primary_10_1177_1087057112456878 crossref_primary_10_4155_fmc_14_147 crossref_primary_10_1590_1678_4324_2017160333 crossref_primary_10_3390_diagnostics14232677 crossref_primary_10_1016_j_cyto_2018_01_002 crossref_primary_10_3389_fphys_2018_01799 crossref_primary_10_1074_jbc_M115_702688 crossref_primary_10_1113_jphysiol_2013_258731 crossref_primary_10_1016_j_ijcard_2015_05_184 crossref_primary_10_1038_s41598_018_34112_4 crossref_primary_10_1161_CIRCHEARTFAILURE_112_967489 crossref_primary_10_1016_j_reprotox_2014_09_013 crossref_primary_10_1016_j_phrs_2020_105414 |
Cites_doi | 10.1161/01.RES.0000099504.30207.F5 10.1152/ajpcell.2001.280.1.C53 10.1016/j.bbrc.2008.03.100 10.1371/journal.pone.0000031 10.1016/j.bbrc.2006.08.052 10.1152/ajpheart.00361.2007 10.1586/erc.10.17 10.1371/journal.pone.0006743 10.1038/onc.2008.308 10.1038/nprot.2008.138 10.1210/en.2006-0728 10.1016/j.yjmcc.2010.12.018 10.1007/s00395-007-0673-0 10.1152/ajpheart.00431.2009 10.1371/journal.pone.0006474 10.1210/en.2004-0985 10.1161/01.CIR.0000084503.91330.49 10.1038/35053000 10.1016/j.yjmcc.2010.04.010 10.1016/j.echo.2005.10.005 10.1002/ccd.1810070304 10.1161/01.RES.0000187457.24338.3D 10.1016/j.bbrc.2005.06.202 10.1152/ajpheart.00157.2009 10.1016/j.tcm.2007.09.005 10.1161/CIRCULATIONAHA.108.783852 10.1091/mbc.E08-06-0587 10.1007/s10495-008-0302-x 10.1016/j.atherosclerosis.2005.02.014 10.4049/jimmunol.174.9.5789 10.1007/s11892-008-0042-x 10.1007/s11010-009-0219-x 10.1016/j.jacc.2008.07.073 10.1016/j.jmb.2006.10.057 10.1006/jmcc.2002.1526 10.1002/biof.63 10.1016/j.yjmcc.2007.08.009 10.1016/S0735-1097(03)00471-6 10.1016/j.yjmcc.2008.05.006 10.1007/s00125-006-0229-0 10.1016/j.cardiores.2006.03.016 10.1177/153537020523001012 10.1172/JCI20785 10.1152/ajpheart.00313.2002 |
ContentType | Journal Article |
Copyright | 2011 Elsevier Ltd Elsevier Ltd Copyright © 2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd. All rights reserved. 2011 |
Copyright_xml | – notice: 2011 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2011 Elsevier Ltd. All rights reserved. – notice: 2011 Elsevier Ltd. All rights reserved. 2011 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.yjmcc.2011.04.006 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1095-8584 |
EndPage | 155 |
ExternalDocumentID | PMC3124590 21549710 10_1016_j_yjmcc_2011_04_006 S0022282811001635 1_s2_0_S0022282811001635 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: K01 HL076659 – fundername: NHLBI NIH HHS grantid: T32 HL007824 – fundername: NHLBI NIH HHS grantid: K01 HL103176 – fundername: National Heart, Lung, and Blood Institute : NHLBI grantid: K01 HL076659-05 || HL |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABGSF ABJNI ABLJU ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADUVX AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HLW HMK HMO HVGLF HZ~ IHE J1W K-O KOM L7B LX2 M29 M41 MO0 N9A O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SBG SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K WUQ X7M XPP Z5R ZGI ZMT ZU3 ~G- AACTN AEHWI AFCTW AFKWA AJOXV AMFUW RIG SSU AAIAV ABLVK ABYKQ AHPSJ AJBFU DOVZS EFLBG LCYCR AAYXX ACLOT CITATION ~HD AGRNS CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c520t-36b62ed4dfe50a48dc451bd3592c9067dbde8693a388957468d1788a4605ec163 |
IEDL.DBID | .~1 |
ISSN | 0022-2828 1095-8584 |
IngestDate | Tue Sep 30 16:35:42 EDT 2025 Sun Sep 28 07:58:22 EDT 2025 Mon Jul 21 06:06:40 EDT 2025 Wed Oct 01 04:42:28 EDT 2025 Thu Apr 24 23:05:25 EDT 2025 Fri Feb 23 02:33:01 EST 2024 Sun Feb 23 10:19:50 EST 2025 Tue Aug 26 16:48:49 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Adeno-associated virus 9 Oxidative stress Fibrosis Diabetic cardiomyopathy Cardiac remodeling Hemodynamics Resistin Apoptosis |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2011 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c520t-36b62ed4dfe50a48dc451bd3592c9067dbde8693a388957468d1788a4605ec163 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ERC and LH contributed equally to this work. Current address: Mitochondria and Metabolism Center, University of Washington, Box 358057 Seattle, WA 98109-4714 |
PMID | 21549710 |
PQID | 874020042 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3124590 proquest_miscellaneous_874020042 pubmed_primary_21549710 crossref_primary_10_1016_j_yjmcc_2011_04_006 crossref_citationtrail_10_1016_j_yjmcc_2011_04_006 elsevier_sciencedirect_doi_10_1016_j_yjmcc_2011_04_006 elsevier_clinicalkeyesjournals_1_s2_0_S0022282811001635 elsevier_clinicalkey_doi_10_1016_j_yjmcc_2011_04_006 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-08-01 |
PublicationDateYYYYMMDD | 2011-08-01 |
PublicationDate_xml | – month: 08 year: 2011 text: 2011-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of molecular and cellular cardiology |
PublicationTitleAlternate | J Mol Cell Cardiol |
PublicationYear | 2011 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Yoon, Lee, Cha, Jeong, Kim, Jang (bb0165) 2010; 49 Kim, Oh, Sakata, Liang, Park, Hajjar (bb0045) 2008; 45 Gualillo, Gonzalez-Juanatey, Lago (bb0025) 2007; 17 Dobrin, Lebeche (bb0140) 2010; 8 Lang, Bierig, Devereux, Flachskampf, Foster, Pellikka (bb0055) 2005; 18 Bokarewa, Nagaev, Dahlberg, Smith, Tarkowski (bb0115) 2005; 174 Westermann, Van Linthout, Dhayat, Dhayat, Schmidt, Noutsias (bb0170) 2007; 102 Cucoranu, Clempus, Dikalova, Phelan, Ariyan, Dikalov (bb0130) 2005; 97 Panek, Posch, Alenina, Ghadge, Erdmann, Popova (bb0155) 2009; 4 Karakikes, Kim, Hadri, Sakata, Sun, Zhang (bb0020) 2009; 4 Gueret, Meerbaum, Zwehl, Wyatt, Davidson, Uchiyama (bb0060) 1981; 7 Harmancey, Taegtmeyer (bb0145) 2008; 8 Choi, Zhong, Hoit, Grupp, Hahn, Dilly (bb0180) 2002; 283 Vafiadaki, Sanoudou, Arvanitis, Catino, Kranias, Kontrogianni-Konstantopoulos (bb0190) 2007; 367 Verma, Li, Wang, Fedak, Li, Weisel (bb0210) 2003; 108 Gao, Chang Chua, Chen, Wang, Xu, Hamdy (bb0030) 2007; 43 Frankel, Vasan, D'Agostino, Benjamin, Levy, Wang (bb0040) 2009; 53 Byrne, Grieve, Bendall, Li, Gove, Lambeth (bb0105) 2003; 93 Sato, Kobayashi, Inoguchi, Sonoda, Imamura, Sekiguchi (bb0075) 2005; 146 Heymes, Bendall, Ratajczak, Cave, Samuel, Hasenfuss (bb0110) 2003; 41 Pacher, Nagayama, Mukhopadhyay, Batkai, Kass (bb0065) 2008; 3 Steppan, Bailey, Bhat, Brown, Banerjee, Wright (bb0005) 2001; 409 Wang, Hung, Chang, Kuan, Shyu (bb0015) 2007; 293 Vandecaetsbeek, Raeymaekers, Wuytack, Vangheluwe (bb0085) 2009; 35 Saha, Xia, Grondin, Engle, Jakubowski (bb0070) 2005; 230 Siwik, Pagano, Colucci (bb0135) 2001; 280 Hayata, Fujio, Yamamoto, Iwakura, Obana, Takai (bb0150) 2008; 370 Suckau, Fechner, Chemaly, Krohn, Hadri, Kockskamper (bb0050) 2009; 119 Vafiadaki, Arvanitis, Pagakis, Papalouka, Sanoudou, Kontrogianni-Konstantopoulos (bb0185) 2009; 20 Burnett, Lee, Kinnaird, Stabile, Durrani, Dullum (bb0010) 2005; 182 Chen, Jiang, Lu, Chai, Wang, Lin (bb0205) 2010; 299 Li, Yang, Ceylan-Isik, Du, Sreejayan, Ren (bb0220) 2006; 49 Umar, van der Laarse (bb0215) 2010; 333 Pinton, Giorgi, Siviero, Zecchini, Rizzuto (bb0195) 2008; 27 Ares-Carrasco, Picatoste, Benito-Martin, Zubiri, Sanz, Sanchez-Nino (bb0175) 2009; 297 Rothwell, Richards, Pemberton (bb0035) 2006; 349 Aragno, Mastrocola, Medana, Catalano, Vercellinatto, Danni (bb0160) 2006; 147 Satoh, Nguyen, Miles, Imamura, Usui, Olefsky (bb0080) 2004; 114 Murdoch, Zhang, Cave, Shah (bb0100) 2006; 71 Nagaev, Bokarewa, Tarkowski, Smith (bb0120) 2006; 1 Maejima, Kuroda, Matsushima, Ago, Sadoshima (bb0090) 2011; 50 Sawyer, Siwik, Xiao, Pimentel, Singh, Colucci (bb0095) 2002; 34 Silswal, Singh, Aruna, Mukhopadhyay, Ghosh, Ehtesham (bb0125) 2005; 334 Lee, Gustafsson (bb0200) 2009; 14 Gualillo (10.1016/j.yjmcc.2011.04.006_bb0025) 2007; 17 Bokarewa (10.1016/j.yjmcc.2011.04.006_bb0115) 2005; 174 Aragno (10.1016/j.yjmcc.2011.04.006_bb0160) 2006; 147 Ares-Carrasco (10.1016/j.yjmcc.2011.04.006_bb0175) 2009; 297 Vafiadaki (10.1016/j.yjmcc.2011.04.006_bb0185) 2009; 20 Burnett (10.1016/j.yjmcc.2011.04.006_bb0010) 2005; 182 Karakikes (10.1016/j.yjmcc.2011.04.006_bb0020) 2009; 4 Wang (10.1016/j.yjmcc.2011.04.006_bb0015) 2007; 293 Harmancey (10.1016/j.yjmcc.2011.04.006_bb0145) 2008; 8 Sawyer (10.1016/j.yjmcc.2011.04.006_bb0095) 2002; 34 Siwik (10.1016/j.yjmcc.2011.04.006_bb0135) 2001; 280 Gao (10.1016/j.yjmcc.2011.04.006_bb0030) 2007; 43 Rothwell (10.1016/j.yjmcc.2011.04.006_bb0035) 2006; 349 Byrne (10.1016/j.yjmcc.2011.04.006_bb0105) 2003; 93 Vandecaetsbeek (10.1016/j.yjmcc.2011.04.006_bb0085) 2009; 35 Maejima (10.1016/j.yjmcc.2011.04.006_bb0090) 2011; 50 Hayata (10.1016/j.yjmcc.2011.04.006_bb0150) 2008; 370 Westermann (10.1016/j.yjmcc.2011.04.006_bb0170) 2007; 102 Pinton (10.1016/j.yjmcc.2011.04.006_bb0195) 2008; 27 Gueret (10.1016/j.yjmcc.2011.04.006_bb0060) 1981; 7 Li (10.1016/j.yjmcc.2011.04.006_bb0220) 2006; 49 Panek (10.1016/j.yjmcc.2011.04.006_bb0155) 2009; 4 Yoon (10.1016/j.yjmcc.2011.04.006_bb0165) 2010; 49 Saha (10.1016/j.yjmcc.2011.04.006_bb0070) 2005; 230 Sato (10.1016/j.yjmcc.2011.04.006_bb0075) 2005; 146 Cucoranu (10.1016/j.yjmcc.2011.04.006_bb0130) 2005; 97 Pacher (10.1016/j.yjmcc.2011.04.006_bb0065) 2008; 3 Kim (10.1016/j.yjmcc.2011.04.006_bb0045) 2008; 45 Murdoch (10.1016/j.yjmcc.2011.04.006_bb0100) 2006; 71 Silswal (10.1016/j.yjmcc.2011.04.006_bb0125) 2005; 334 Suckau (10.1016/j.yjmcc.2011.04.006_bb0050) 2009; 119 Frankel (10.1016/j.yjmcc.2011.04.006_bb0040) 2009; 53 Dobrin (10.1016/j.yjmcc.2011.04.006_bb0140) 2010; 8 Lee (10.1016/j.yjmcc.2011.04.006_bb0200) 2009; 14 Vafiadaki (10.1016/j.yjmcc.2011.04.006_bb0190) 2007; 367 Verma (10.1016/j.yjmcc.2011.04.006_bb0210) 2003; 108 Heymes (10.1016/j.yjmcc.2011.04.006_bb0110) 2003; 41 Chen (10.1016/j.yjmcc.2011.04.006_bb0205) 2010; 299 Steppan (10.1016/j.yjmcc.2011.04.006_bb0005) 2001; 409 Nagaev (10.1016/j.yjmcc.2011.04.006_bb0120) 2006; 1 Lang (10.1016/j.yjmcc.2011.04.006_bb0055) 2005; 18 Satoh (10.1016/j.yjmcc.2011.04.006_bb0080) 2004; 114 Choi (10.1016/j.yjmcc.2011.04.006_bb0180) 2002; 283 Umar (10.1016/j.yjmcc.2011.04.006_bb0215) 2010; 333 |
References_xml | – volume: 114 start-page: 224 year: 2004 end-page: 231 ident: bb0080 article-title: Adenovirus-mediated chronic “hyper-resistinemia” leads to publication-title: J Clin Invest – volume: 27 start-page: 6407 year: 2008 end-page: 6418 ident: bb0195 article-title: Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis publication-title: Oncogene – volume: 14 start-page: 536 year: 2009 end-page: 548 ident: bb0200 article-title: Role of apoptosis in cardiovascular disease publication-title: Apoptosis – volume: 34 start-page: 379 year: 2002 end-page: 388 ident: bb0095 article-title: Role of oxidative stress in myocardial hypertrophy and failure publication-title: J Mol Cell Cardiol – volume: 45 start-page: 270 year: 2008 end-page: 280 ident: bb0045 article-title: Role of resistin in cardiac contractility and hypertrophy publication-title: J Mol Cell Cardiol – volume: 49 start-page: 294 year: 2010 end-page: 303 ident: bb0165 article-title: The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis publication-title: J Mol Cell Cardiol – volume: 50 start-page: 408 year: 2011 end-page: 416 ident: bb0090 article-title: Regulation of myocardial growth and death by NADPH oxidase publication-title: J Mol Cell Cardiol – volume: 93 start-page: 802 year: 2003 end-page: 805 ident: bb0105 article-title: Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy publication-title: Circ Res – volume: 1 start-page: e31 year: 2006 ident: bb0120 article-title: Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes publication-title: PLoS One – volume: 280 start-page: C53 year: 2001 end-page: C60 ident: bb0135 article-title: Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts publication-title: Am J Physiol – volume: 119 start-page: 1241 year: 2009 end-page: 1252 ident: bb0050 article-title: Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy publication-title: Circulation – volume: 174 start-page: 5789 year: 2005 end-page: 5795 ident: bb0115 article-title: Resistin, an adipokine with potent proinflammatory properties publication-title: J Immunol – volume: 293 start-page: H2305 year: 2007 end-page: H2312 ident: bb0015 article-title: Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes publication-title: Am J Physiol Heart Circ Physiol – volume: 35 start-page: 484 year: 2009 end-page: 499 ident: bb0085 article-title: Factors controlling the activity of the SERCA2a pump in the normal and failing heart publication-title: Biofactors – volume: 409 start-page: 307 year: 2001 end-page: 312 ident: bb0005 article-title: The hormone resistin links obesity to diabetes publication-title: Nature – volume: 334 start-page: 1092 year: 2005 end-page: 1101 ident: bb0125 article-title: Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway publication-title: Biochem Biophys Res Commun – volume: 349 start-page: 400 year: 2006 end-page: 407 ident: bb0035 article-title: Resistin worsens cardiac ischaemia–reperfusion injury publication-title: Biochem Biophys Res Commun – volume: 8 start-page: 373 year: 2010 end-page: 391 ident: bb0140 article-title: Diabetic cardiomyopathy: signaling defects and therapeutic approaches publication-title: Expert Rev Cardiovasc Ther – volume: 299 start-page: H193 year: 2010 end-page: H201 ident: bb0205 article-title: Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells publication-title: Am J Physiol Heart Circ Physiol – volume: 53 start-page: 754 year: 2009 end-page: 762 ident: bb0040 article-title: Resistin, adiponectin, and risk of heart failure the Framingham offspring study publication-title: J Am Coll Cardiol – volume: 97 start-page: 900 year: 2005 end-page: 907 ident: bb0130 article-title: NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts publication-title: Circ Res – volume: 71 start-page: 208 year: 2006 end-page: 215 ident: bb0100 article-title: NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure publication-title: Cardiovasc Res – volume: 18 start-page: 1440 year: 2005 end-page: 1463 ident: bb0055 article-title: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology publication-title: J Am Soc Echocardiogr – volume: 230 start-page: 777 year: 2005 end-page: 784 ident: bb0070 article-title: Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models publication-title: Exp Biol Med – volume: 333 start-page: 191 year: 2010 end-page: 201 ident: bb0215 article-title: Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart publication-title: Mol Cell Biochem – volume: 49 start-page: 1434 year: 2006 end-page: 1446 ident: bb0220 article-title: Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+−ATPase and myosin heavy chain isozyme switch publication-title: Diabetologia – volume: 4 start-page: e6743 year: 2009 ident: bb0155 article-title: Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload publication-title: PLoS One – volume: 297 start-page: H2109 year: 2009 end-page: H2119 ident: bb0175 article-title: Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes publication-title: Am J Physiol Heart Circ Physiol – volume: 108 start-page: 736 year: 2003 end-page: 740 ident: bb0210 article-title: Resistin promotes endothelial cell activation: further evidence of adipokine–endothelial interaction publication-title: Circulation – volume: 370 start-page: 274 year: 2008 end-page: 278 ident: bb0150 article-title: Connective tissue growth factor induces cardiac hypertrophy through Akt signaling publication-title: Biochem Biophys Res Commun – volume: 367 start-page: 65 year: 2007 end-page: 79 ident: bb0190 article-title: Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function publication-title: J Mol Biol – volume: 7 start-page: 247 year: 1981 end-page: 258 ident: bb0060 article-title: Two-dimensional echocardiographic assessment of left ventricular stroke volume: experimental correlation with thermodilution and cineangiography in normal and ischemic states publication-title: Cathet Cardiovasc Diagn – volume: 3 start-page: 1422 year: 2008 end-page: 1434 ident: bb0065 article-title: Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats publication-title: Nat Protoc – volume: 283 start-page: H1398 year: 2002 end-page: H1408 ident: bb0180 article-title: Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats publication-title: Am J Physiol Heart Circ Physiol – volume: 182 start-page: 241 year: 2005 end-page: 248 ident: bb0010 article-title: The potential role of resistin in atherogenesis publication-title: Atherosclerosis – volume: 102 start-page: 500 year: 2007 end-page: 507 ident: bb0170 article-title: Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy publication-title: Basic Res Cardiol – volume: 20 start-page: 306 year: 2009 end-page: 318 ident: bb0185 article-title: The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival publication-title: Mol Biol Cell – volume: 43 start-page: 601 year: 2007 end-page: 609 ident: bb0030 article-title: Resistin, an adipocytokine, offers protection against acute myocardial infarction publication-title: J Mol Cell Cardiol – volume: 147 start-page: 5967 year: 2006 end-page: 5974 ident: bb0160 article-title: Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes publication-title: Endocrinology – volume: 41 start-page: 2164 year: 2003 end-page: 2171 ident: bb0110 article-title: Increased myocardial NADPH oxidase activity in human heart failure publication-title: J Am Coll Cardiol – volume: 4 start-page: e6474 year: 2009 ident: bb0020 article-title: Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a publication-title: PLoS One – volume: 17 start-page: 275 year: 2007 end-page: 283 ident: bb0025 article-title: The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives publication-title: Trends Cardiovasc Med – volume: 146 start-page: 273 year: 2005 end-page: 279 ident: bb0075 article-title: Adenovirus-mediated high expression of resistin causes dyslipidemia in mice publication-title: Endocrinology – volume: 8 start-page: 243 year: 2008 end-page: 248 ident: bb0145 article-title: The complexities of diabetic cardiomyopathy: lessons from patients and animal models publication-title: Curr Diab Rep – volume: 93 start-page: 802 issue: 9 year: 2003 ident: 10.1016/j.yjmcc.2011.04.006_bb0105 article-title: Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy publication-title: Circ Res doi: 10.1161/01.RES.0000099504.30207.F5 – volume: 280 start-page: C53 issue: 1 year: 2001 ident: 10.1016/j.yjmcc.2011.04.006_bb0135 article-title: Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts publication-title: Am J Physiol doi: 10.1152/ajpcell.2001.280.1.C53 – volume: 370 start-page: 274 issue: 2 year: 2008 ident: 10.1016/j.yjmcc.2011.04.006_bb0150 article-title: Connective tissue growth factor induces cardiac hypertrophy through Akt signaling publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2008.03.100 – volume: 1 start-page: e31 year: 2006 ident: 10.1016/j.yjmcc.2011.04.006_bb0120 article-title: Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes publication-title: PLoS One doi: 10.1371/journal.pone.0000031 – volume: 349 start-page: 400 issue: 1 year: 2006 ident: 10.1016/j.yjmcc.2011.04.006_bb0035 article-title: Resistin worsens cardiac ischaemia–reperfusion injury publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2006.08.052 – volume: 293 start-page: H2305 issue: 4 year: 2007 ident: 10.1016/j.yjmcc.2011.04.006_bb0015 article-title: Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes via tumor necrosis factor-alpha publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00361.2007 – volume: 8 start-page: 373 issue: 3 year: 2010 ident: 10.1016/j.yjmcc.2011.04.006_bb0140 article-title: Diabetic cardiomyopathy: signaling defects and therapeutic approaches publication-title: Expert Rev Cardiovasc Ther doi: 10.1586/erc.10.17 – volume: 4 start-page: e6743 issue: 8 year: 2009 ident: 10.1016/j.yjmcc.2011.04.006_bb0155 article-title: Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload publication-title: PLoS One doi: 10.1371/journal.pone.0006743 – volume: 27 start-page: 6407 issue: 50 year: 2008 ident: 10.1016/j.yjmcc.2011.04.006_bb0195 article-title: Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis publication-title: Oncogene doi: 10.1038/onc.2008.308 – volume: 3 start-page: 1422 issue: 9 year: 2008 ident: 10.1016/j.yjmcc.2011.04.006_bb0065 article-title: Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats publication-title: Nat Protoc doi: 10.1038/nprot.2008.138 – volume: 147 start-page: 5967 issue: 12 year: 2006 ident: 10.1016/j.yjmcc.2011.04.006_bb0160 article-title: Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes publication-title: Endocrinology doi: 10.1210/en.2006-0728 – volume: 50 start-page: 408 issue: 3 year: 2011 ident: 10.1016/j.yjmcc.2011.04.006_bb0090 article-title: Regulation of myocardial growth and death by NADPH oxidase publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2010.12.018 – volume: 102 start-page: 500 issue: 6 year: 2007 ident: 10.1016/j.yjmcc.2011.04.006_bb0170 article-title: Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy publication-title: Basic Res Cardiol doi: 10.1007/s00395-007-0673-0 – volume: 299 start-page: H193 issue: 1 year: 2010 ident: 10.1016/j.yjmcc.2011.04.006_bb0205 article-title: Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00431.2009 – volume: 4 start-page: e6474 issue: 7 year: 2009 ident: 10.1016/j.yjmcc.2011.04.006_bb0020 article-title: Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a publication-title: PLoS One doi: 10.1371/journal.pone.0006474 – volume: 146 start-page: 273 issue: 1 year: 2005 ident: 10.1016/j.yjmcc.2011.04.006_bb0075 article-title: Adenovirus-mediated high expression of resistin causes dyslipidemia in mice publication-title: Endocrinology doi: 10.1210/en.2004-0985 – volume: 108 start-page: 736 issue: 6 year: 2003 ident: 10.1016/j.yjmcc.2011.04.006_bb0210 article-title: Resistin promotes endothelial cell activation: further evidence of adipokine–endothelial interaction publication-title: Circulation doi: 10.1161/01.CIR.0000084503.91330.49 – volume: 409 start-page: 307 issue: 6818 year: 2001 ident: 10.1016/j.yjmcc.2011.04.006_bb0005 article-title: The hormone resistin links obesity to diabetes publication-title: Nature doi: 10.1038/35053000 – volume: 49 start-page: 294 issue: 2 year: 2010 ident: 10.1016/j.yjmcc.2011.04.006_bb0165 article-title: The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2010.04.010 – volume: 18 start-page: 1440 issue: 12 year: 2005 ident: 10.1016/j.yjmcc.2011.04.006_bb0055 publication-title: J Am Soc Echocardiogr doi: 10.1016/j.echo.2005.10.005 – volume: 7 start-page: 247 issue: 3 year: 1981 ident: 10.1016/j.yjmcc.2011.04.006_bb0060 article-title: Two-dimensional echocardiographic assessment of left ventricular stroke volume: experimental correlation with thermodilution and cineangiography in normal and ischemic states publication-title: Cathet Cardiovasc Diagn doi: 10.1002/ccd.1810070304 – volume: 97 start-page: 900 issue: 9 year: 2005 ident: 10.1016/j.yjmcc.2011.04.006_bb0130 article-title: NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts publication-title: Circ Res doi: 10.1161/01.RES.0000187457.24338.3D – volume: 334 start-page: 1092 issue: 4 year: 2005 ident: 10.1016/j.yjmcc.2011.04.006_bb0125 article-title: Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2005.06.202 – volume: 297 start-page: H2109 issue: 6 year: 2009 ident: 10.1016/j.yjmcc.2011.04.006_bb0175 article-title: Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00157.2009 – volume: 17 start-page: 275 issue: 8 year: 2007 ident: 10.1016/j.yjmcc.2011.04.006_bb0025 article-title: The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives publication-title: Trends Cardiovasc Med doi: 10.1016/j.tcm.2007.09.005 – volume: 119 start-page: 1241 issue: 9 year: 2009 ident: 10.1016/j.yjmcc.2011.04.006_bb0050 article-title: Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.783852 – volume: 20 start-page: 306 issue: 1 year: 2009 ident: 10.1016/j.yjmcc.2011.04.006_bb0185 article-title: The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival publication-title: Mol Biol Cell doi: 10.1091/mbc.E08-06-0587 – volume: 14 start-page: 536 issue: 4 year: 2009 ident: 10.1016/j.yjmcc.2011.04.006_bb0200 article-title: Role of apoptosis in cardiovascular disease publication-title: Apoptosis doi: 10.1007/s10495-008-0302-x – volume: 182 start-page: 241 issue: 2 year: 2005 ident: 10.1016/j.yjmcc.2011.04.006_bb0010 article-title: The potential role of resistin in atherogenesis publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2005.02.014 – volume: 174 start-page: 5789 issue: 9 year: 2005 ident: 10.1016/j.yjmcc.2011.04.006_bb0115 article-title: Resistin, an adipokine with potent proinflammatory properties publication-title: J Immunol doi: 10.4049/jimmunol.174.9.5789 – volume: 8 start-page: 243 issue: 3 year: 2008 ident: 10.1016/j.yjmcc.2011.04.006_bb0145 article-title: The complexities of diabetic cardiomyopathy: lessons from patients and animal models publication-title: Curr Diab Rep doi: 10.1007/s11892-008-0042-x – volume: 333 start-page: 191 issue: 1–2 year: 2010 ident: 10.1016/j.yjmcc.2011.04.006_bb0215 article-title: Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart publication-title: Mol Cell Biochem doi: 10.1007/s11010-009-0219-x – volume: 53 start-page: 754 issue: 9 year: 2009 ident: 10.1016/j.yjmcc.2011.04.006_bb0040 article-title: Resistin, adiponectin, and risk of heart failure the Framingham offspring study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.07.073 – volume: 367 start-page: 65 issue: 1 year: 2007 ident: 10.1016/j.yjmcc.2011.04.006_bb0190 article-title: Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function publication-title: J Mol Biol doi: 10.1016/j.jmb.2006.10.057 – volume: 34 start-page: 379 issue: 4 year: 2002 ident: 10.1016/j.yjmcc.2011.04.006_bb0095 article-title: Role of oxidative stress in myocardial hypertrophy and failure publication-title: J Mol Cell Cardiol doi: 10.1006/jmcc.2002.1526 – volume: 35 start-page: 484 issue: 6 year: 2009 ident: 10.1016/j.yjmcc.2011.04.006_bb0085 article-title: Factors controlling the activity of the SERCA2a pump in the normal and failing heart publication-title: Biofactors doi: 10.1002/biof.63 – volume: 43 start-page: 601 issue: 5 year: 2007 ident: 10.1016/j.yjmcc.2011.04.006_bb0030 article-title: Resistin, an adipocytokine, offers protection against acute myocardial infarction publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2007.08.009 – volume: 41 start-page: 2164 issue: 12 year: 2003 ident: 10.1016/j.yjmcc.2011.04.006_bb0110 article-title: Increased myocardial NADPH oxidase activity in human heart failure publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)00471-6 – volume: 45 start-page: 270 issue: 2 year: 2008 ident: 10.1016/j.yjmcc.2011.04.006_bb0045 article-title: Role of resistin in cardiac contractility and hypertrophy publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2008.05.006 – volume: 49 start-page: 1434 issue: 6 year: 2006 ident: 10.1016/j.yjmcc.2011.04.006_bb0220 article-title: Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+−ATPase and myosin heavy chain isozyme switch publication-title: Diabetologia doi: 10.1007/s00125-006-0229-0 – volume: 71 start-page: 208 issue: 2 year: 2006 ident: 10.1016/j.yjmcc.2011.04.006_bb0100 article-title: NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2006.03.016 – volume: 230 start-page: 777 issue: 10 year: 2005 ident: 10.1016/j.yjmcc.2011.04.006_bb0070 article-title: Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models publication-title: Exp Biol Med doi: 10.1177/153537020523001012 – volume: 114 start-page: 224 issue: 2 year: 2004 ident: 10.1016/j.yjmcc.2011.04.006_bb0080 article-title: Adenovirus-mediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats publication-title: J Clin Invest doi: 10.1172/JCI20785 – volume: 283 start-page: H1398 issue: 4 year: 2002 ident: 10.1016/j.yjmcc.2011.04.006_bb0180 article-title: Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00313.2002 |
SSID | ssj0009433 |
Score | 2.3191636 |
Snippet | We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term cardiovascular... Abstract We have previously reported that resistin induces hypertrophy and impairs contractility in isolated rat cardiomyocytes. To examine the long-term... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 144 |
SubjectTerms | Adeno-associated virus 9 Animals Apoptosis Apoptosis - genetics Biomarkers - metabolism Blood Glucose - genetics Cardiac remodeling Cardiovascular Cells, Cultured Diabetic cardiomyopathy Fibrosis Fibrosis - genetics Gene Expression - genetics Gene Expression Regulation Heart - physiopathology Heart Ventricles - metabolism Heart Ventricles - pathology Heart Ventricles - physiopathology Hemodynamics Hemodynamics - genetics Hypertrophy, Left Ventricular - genetics Hypertrophy, Left Ventricular - metabolism Hypertrophy, Left Ventricular - pathology Inflammation Mediators - metabolism Male Myocardium - enzymology Myocardium - metabolism Myocardium - pathology Myocytes, Cardiac - enzymology Myocytes, Cardiac - metabolism Myocytes, Cardiac - pathology Nitric Oxide Synthase - genetics Nitric Oxide Synthase - metabolism Oxidative stress Oxidative Stress - genetics Rats Rats, Sprague-Dawley Resistin Resistin - genetics Resistin - metabolism Ventricular Remodeling - genetics |
Title | Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0022282811001635 https://www.clinicalkey.es/playcontent/1-s2.0-S0022282811001635 https://dx.doi.org/10.1016/j.yjmcc.2011.04.006 https://www.ncbi.nlm.nih.gov/pubmed/21549710 https://www.proquest.com/docview/874020042 https://pubmed.ncbi.nlm.nih.gov/PMC3124590 |
Volume | 51 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1095-8584 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009433 issn: 0022-2828 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1095-8584 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009433 issn: 0022-2828 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1095-8584 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009433 issn: 0022-2828 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1095-8584 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009433 issn: 0022-2828 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1095-8584 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009433 issn: 0022-2828 databaseCode: AKRWK dateStart: 19700301 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED8hJqG9TPtex0B-2OMyEsdxnUeEhrp18ICGxpvl2O4WBC4iBdEX_nbuEqfQsTEJqVLU5i51fOe7s33-HcDHiZPSmlImGAupROR8khiPX9F5p6qiGYmlpYG9fTk6FN-OiqMV2OnPwlBaZbT9nU1vrXX8ZSv25tZZXdMZX1q94IpAzzCqoIPmhP6FOv35-jbNoxRdOXnKWifqHnmozfGaH59aG3E8CUVb_ss73Y8-_0yivOOVdp_DsxhOsu2uxS9gxYeXsLYXN8xfgf4-Db8SMr-sDuyyvpwynF_TuA6Mkjf9VUyEDXjfoZgbdjpH90Zqc8LcvCG_R7JjJjhkbQvnoLejp6HuNK_hcPfLj51REmsqJLbg6SzJZSW5d8JNfJEaoZwVRVa5vCi5LdFzucp5Jcvc5EqVxVBI5TKcJRvaPvUWu_kNrIZp8O-AIaksTeYdEgtnssoOvcqrAj9imFdqALzvS20j4DjVvTjRfWbZsW4FoEkAOhUaBTCATwumsw5v42Fy0QtJ90dJ0fhp9AcPsw3_xuabOIAbnemG61TfU7IByAXnkp7-_y9Zr0MaRzBty5jgpxeNpqKIZKv4AN52KrV4c04AehgDYnuXlG1BQODgy3dC_bsFCc8xcCvK9P1j27sOT_vl8zT7AKuz8wu_gfHXrNpsB9gmPNn-Oh7t03V88HN8AyDZMvI |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTgJeEJ-j48sPPBItcWzXeZwmpo61fdqkvVmJ7UKmzZ1IN9H_fneJUyiDISHlJbEvcXznu7N9_h3Ax7lTypaFStAX0onI-TwpPd6i8U51RTMSS0sD05kan4ovZ_JsCw76szAUVhl1f6fTW20dn-zF3ty7qms640urF1wT6Bl6FfIBbAuJOnkA2_tHx-PZT-xd0WWUp8B1IujBh9owr9X5pbURypOAtNXfDNRdB_T3OMpfDNPhU3gSPUq23zX6GWz58BweTuOe-Qswk0X4mpAGZnVgN_XNguEUm4Z2YBS_6X_EWNiA5Q453bDLFVo4kpwL5lYNmT5iHyuDQ9I2dw4aPHobik_zEk4PP58cjJOYViGxkqfLJFeV4t4JN_cyLYV2VsiscrksuC3QeLnKea2KvMy1LuRIKO0ynCiXtIPqLfb0KxiERfCvgWFVVZSZd1hZuDKr7MjrvJJ4iVFe6SHwvi-NjZjjlPriwvTBZeemZYAhBphUGGTAED6tia46yI37q4ueSaY_TYr6z6BJuJ9s9Ccy38Qx3JjMNNyk5o6cDUGtKTdE9d-fZL0MGRzEtDNTBr-4bgzlRSR1xYew04nU-s85YeihG4jt3RC2dQXCB98sCfW3Fic8R99NFunu_7b3Azwan0wnZnI0O34Dj_vV9DR7C4Pl92v_Dt2xZfU-Drdb0LAz-g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+in+vivo+resistin+overexpression+induces+myocardial+dysfunction+and+remodeling+in+rats&rft.jtitle=Journal+of+molecular+and+cellular+cardiology&rft.au=Chemaly%2C+Elie+R.&rft.au=Hadri%2C+Lahouaria&rft.au=Zhang%2C+Shihong&rft.au=Kim%2C+Maengjo&rft.date=2011-08-01&rft.issn=0022-2828&rft.volume=51&rft.issue=2&rft.spage=144&rft.epage=155&rft_id=info:doi/10.1016%2Fj.yjmcc.2011.04.006&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_yjmcc_2011_04_006 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00222828%2FS0022282811X00081%2Fcov150h.gif |